Filgrastim biosimilar - CT Arzneimittel

Drug Profile

Filgrastim biosimilar - CT Arzneimittel

Alternative Names: Biograstim (CT Arzneimittel)

Latest Information Update: 16 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CT Arzneimittel
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
  • Mechanism of Action Haematopoietic cell growth factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Neutropenia

Most Recent Events

  • 16 May 2016 Launched for Neutropenia in Slovakia and Lithuania (IV), (SC) before May 2016
  • 08 Aug 2013 Biomarkers information updated
  • 04 Apr 2011 Launched for Neutropenia in Germany, Ireland, Netherlands, Poland, Portugal and Czech Republic (IV, infusion) after September 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top